Merrimack Pharma shares owned by UBS Group
Quarter-by-quarter ownership of Merrimack Pharma shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Merrimack Pharma
Tip: Access up to 7 years of quarterly data
All positions including Merrimack Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Merrimack Pharma by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $184k | 12k | 14.77 |
2023-12-31 | $177k | 13k | 13.41 |
2023-09-30 | $72k | 5.8k | 12.33 |
2023-06-30 | $81k | 6.6k | 12.30 |
2023-03-31 | $38k | 3.1k | 12.29 |
2022-12-31 | $8.9k | 775 | 11.46 |
2022-09-30 | $0 | 5.2k | 0.00 |
2022-06-30 | $12k | 1.2k | 10.00 |
2022-03-31 | $23k | 2.3k | 10.00 |
2021-12-31 | $999 | 197 | 5.08 |
2021-09-30 | $999 | 197 | 5.08 |
2021-06-30 | $2.5k | 499 | 5.08 |
2021-03-31 | $10k | 1.7k | 6.02 |
2020-12-31 | $999 | 197 | 5.08 |
2020-09-30 | $999 | 197 | 5.08 |
2020-06-30 | $999 | 197 | 5.08 |
2020-03-31 | $5.4k | 2.6k | 2.12 |
2019-12-31 | $1.0k | 197 | 5.08 |
2019-09-30 | $14k | 2.8k | 5.03 |
2019-06-30 | $4.0k | 597 | 6.70 |
2019-03-31 | $13k | 2.1k | 6.04 |
2018-12-31 | $16k | 3.9k | 4.02 |
2018-09-30 | $13k | 2.2k | 6.04 |
2018-06-30 | $11k | 2.1k | 5.10 |
2018-03-31 | $4.0k | 517 | 7.74 |
2017-12-31 | $70k | 6.8k | 10.37 |
2017-09-30 | $105k | 7.3k | 14.46 |